Search Orphan Drug Designations and Approvals
-
Generic Name: | Fibronectin Peptide |
---|---|
Date Designated: | 06/29/2011 |
Orphan Designation: | Prevention of burn injury progression of acute, deep dermal burns in hospitalized patients. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
NeoMatrix Therapeutics, Inc. Long Island High Tech Incubator 25 Health Sciences Drive Stony Brook, New York 11790 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-